![]() |
Volumn 64, Issue 6-7, 1999, Pages 457-464
|
Tiotropium (spiriva(TM)): Mechanistical considerations and clinical profile in obstructive lung disease
a
|
Author keywords
Bronchodilator; COPD; Long acting antimuscarinic; Specific muscarinic; Tiotropium
|
Indexed keywords
CHOLINERGIC RECEPTOR BLOCKING AGENT;
IPRATROPIUM BROMIDE;
METHACHOLINE;
MUSCARINIC M2 RECEPTOR;
MUSCARINIC RECEPTOR BLOCKING AGENT;
RECEPTOR SUBTYPE;
TIOTROPIUM BROMIDE;
UNCLASSIFIED DRUG;
BRONCHODILATING AGENT;
MUSCARINIC AGENT;
MUSCARINIC RECEPTOR;
SCOPOLAMINE DERIVATIVE;
TIOTROPIUM;
ASTHMA;
BRONCHODILATATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISSOCIATION;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DYSPNEA;
GEOMETRY;
GUINEA PIG;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LUNG FUNCTION TEST;
NONHUMAN;
RANDOMIZED CONTROLLED TRIAL;
ANIMAL;
BINDING SITE;
BLOOD;
CELL MEMBRANE;
DOSE RESPONSE;
METABOLISM;
REVIEW;
CAVIA PORCELLUS;
SUS SCROFA;
ANIMALS;
ASTHMA;
BINDING SITES;
BRONCHODILATOR AGENTS;
CELL MEMBRANE;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
MUSCARINIC AGONISTS;
MUSCARINIC ANTAGONISTS;
RECEPTORS, MUSCARINIC;
SCOPOLAMINE DERIVATIVES;
|
EID: 0033534194
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(98)00588-8 Document Type: Conference Paper |
Times cited : (269)
|
References (20)
|